Table 2. ART initiation, 10-mo retention in care, and 10-mo viral suppression.

Outcome	Standard arm(%)n = 190	Rapid arm(%)n = 187	Crude risk difference(95% CI)	Crude relative risk(95% CI)
Initiated ≤ 90 d and suppressed by 10 mo (primary outcome)	96 (51%)	119 (64%)	13% (3%–23%)	1.26 (1.05–1.50)
Of those not initiated ≤ 90 d and suppressed by 10 mo	94 (49%)	68 (36%)
Not initiated	54 (28%)	5 (3%)
Initiated but not suppressed	40 (21%)	63 (34%)
Of those initiated but not suppressed:
Retained, unsuppressed viral load test reported	11 (6%)	17 (9%)
Retained, no viral load test reported	14 (7%)	16 (9%)
Transferred to another clinic	1 (1%)	6 (3%)
Died	3 (2%)	0 (0%)
Lost to follow-up	11 (6%)	24 (13%)
Initiated ≤ 90 d	136 (72%)	182 (97%)	25% (19%–33%)	1.36 (1.24–1.49)
Initiated ≤ 90 d and retained at 10 mo (secondary outcome)	121 (64%)	151 (81%)	17% (5%–23%)	1.27 (1.12–1.44)
Of those not initiated ≤ 90 d and retained at 10 mo:	69 (36%)	36 (19%)
Initiated but not retained	15 (8%)	31 (17%)
Not initiated	54 (28%)	5 (3%)